Endomag
Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.
Endomag has raised €17M across 1 funding round from 1 investor, most recently a Series D+ round in Nov 2020. Based in Cambridge, UK; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€17M
€16,770,645
Funding rounds
1
Investors
1
distinct backers
Active since
2020-11
latest 2020-11
Funding by year
EUR raised per yearEndomag — funding by year — interactive chart.
Data table
| Endomag — funding by year | |
|---|---|
| 2020 | €17M |
Signals
High confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-30 | Series D+ | €17M | Draper Esprit | View deal → |